An article in the April 16, 2002, issue of BioWorld Today should have said Novirio Pharmaceuticals Ltd.’s initial public offering is being co-led by Goldman Sachs & Co., of New York, and Banc of America Securities LLC, of San Francisco.

Editor’s Note: The correction has been made in BioWorld Online.